Vericel Corporation (VCEL) Stock Forecast

NASDAQ: VCELAnalyst ratings, price target and estimates.

VCEL analyst forecast

as of October 18, 2026
Analyst consensus
Strong buy
4.75 / 5 from 8 analysts
Price target
$59.71
average of analyst targets
Upside to target
+48.8%
from the latest close
Next earnings
November 5, 2026
EPS estimate $0.02
52-week range
$29.34 – $48.31

VCEL analyst ratings

8 analysts
Strong buy
788%
Buy
00%
Hold
112%
Sell
00%
Strong sell
00%

Number of analysts at each rating.

VCEL price target

Price $40.13Target $59.71
52-week low $29.3452-week high $48.31

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

VCEL earnings per share estimates

Vericel Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$0.06$0.02$0.10$0.10−44.0%5
Current fiscal year (2026)$0.52$0.44$0.70$0.32+61.3%5
Next fiscal year (2027)$0.85$0.68$1.03$0.52+63.9%5

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

VCEL revenue estimates

Vericel Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$78.0M$77.4M$78.4M+15.5%8
Current fiscal year (2026)$336.2M$335.2M$339.9M+21.7%8
Next fiscal year (2027)$392.9M$386.4M$407.6M+16.9%8

VCEL EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

VCEL revenue: reported and forecast

Reported revenueEstimate (average; low–high)

VCEL EPS estimate revisions

Vericel Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$0.09$0.08$0.06$0.06$0.06−34.1%1 up · 0 down
Current fiscal year (2026)$0.45$0.45$0.52$0.52$0.52+14.2%1 up · 0 down
Next fiscal year (2027)$0.85$0.85$0.85$0.85$0.85−0.7%1 up · 0 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

VCEL earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; VCEL beat in 10 of 12.

What analysts expect from VCEL

8 analysts cover Vericel; their consensus rating is strong buy (4.75 on a 1–5 scale, where 5 is a strong buy). The average price target is $59.71, 48.8% above the latest close of $40.13. Analysts expect earnings of $0.52 per share for 2026, +61.3% from a year earlier. For 2027 the average estimate is $0.85 per share on revenue of $392.9 million. Vericel beat the EPS estimate in 10 of the last 12 quarters.

Related: VCEL income statement, VCEL key metrics, VCEL chart. See the VCEL stock overview for the latest quote and news.

VCEL forecast FAQ

What is Vericel's price target?

The average analyst price target for Vericel is $59.71, 48.8% above the latest close of $40.13.

Is Vericel a buy, hold or sell?

Of 8 analysts covering Vericel, 7 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Vericel's EPS forecast?

Analysts forecast $0.52 per share for 2026 (range $0.44 to $0.70); for 2027 the estimate is $0.85.

What is Vericel's revenue forecast?

The average revenue estimate for 2026 is $336.2 million, growth of 21.7%; for 2027 it is $392.9 million.

When does Vericel report earnings?

Vericel is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $0.02.

Does Vericel usually beat earnings estimates?

Vericel reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Biotechnology: forecast